Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. The broad stock runup in the first half of 2013 was a boon to ClearBridge Aggressive

Ionis Pharmaceuticals stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

The trading price of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) floating lower at last check on Wednesday, Apr 07, closing at $47.25, -4.44% lower than its previous close. Get the hottest stocks to trade every day before the market opens 100% free. 2021-04-08 · During the recent session, Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)’s traded shares were 2,150,534, with the beta value of the company hitting 1.1. At the last check, the stock’s price was $43.37, reflecting an intraday loss of -0.65% or -$0.28. 2021-04-09 · View Ionis Pharmaceuticals, Inc. IONS investment & stock information. Get the latest Ionis Pharmaceuticals, Inc. IONS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Ionis stock

IONS / Ionis Pharmaceuticals Inc financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Ionis Pharmaceuticals Upside Post Covid: IONS Stock (Down 23% YTD) Has 43 % Upside If It Recovers To Pre-Covid Levels During The 2008 Recession It Lost View Ionis Pharmaceuticals, Inc. IONS investment & stock information. Get the latest Ionis Pharmaceuticals, Inc. IONS detailed stock quotes, stock data, Aug 31, 2020 Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash; Transaction drives efficiencies, Mar 5, 2020 A 20-patient Phase 1 study of an RNA drug discovered by Ionis Ionis's stock price fell 3 percent as of market close Thursday under pressure Aug 28, 2018 Shares of Ionis Pharmaceuticals and spinout Akcea Therapeutics kept falling Tuesday morning after a U.S. Food and Drug Administration View live IONIS PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, IONS financials and market news. SUMMARY - IONS: Ionis Pharmaceuticals Inc. CLOSING IONS STOCK PRICE $44.71. 52 WEEK HIGH STOCK PRICE $64.37. 52 WEEK LOW STOCK PRICE Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that intended to treat homozygous familial hypercholesterolemia and other drug candidates; the deal included Genzyme buying $150 million of Isis stock and Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för Ionis Pharmaceuticals Inc aktien.

Ionis is traded on the NASDAQ stock exchange under the symbol IONS. Please note that prior to December 22, 2015 our symbol was ISIS and prior to February 21, 2002 our symbol was ISIP. How can I get a copy of your annual report? To view a PDF file of the annual reports from 2016-2019 click here.

Ionis Pharmaceuticals stock (NASDAQ: IONS), a biotech company that specializes in discovering and developing RNA-targeted therapeutics, has more room for growth in the near term. 2021-03-23 1 day ago 17 hours ago Ionis Pharmaceuticals Inc stock has fallen -1.32% over the last 12 months, and the average rating from Wall Street analysts is a Hold.InvestorsObserver’s proprietary ranking system, gives IONS stock a score of 29 out of a possible 100.. That rank is influenced by a short-term technical score of 9. IONS's rank also includes a long-term technical score of 15.

2021-04-08 · Ionis Pharmaceuticals Inc IONS. Ionis Pharmaceuticals Inc. IONS. Morningstar Rating. Rating as of Apr 2, 2021. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation

Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).

Activision Blizzard Inc Common Stock, 796714102, 0,11%, 1008330. PNC Financial Ionis Pharmaceuticals Inc, 64451473, 0,01%, 143214. Grupo Televisa Amalgamated Bank - Class A · Canada Goose Holdings Inc · Waitr Holdings Inc. Cyclo Therapeutics, Inc. Common Stock · NewJersey Resources Corporation.
Aml jobb göteborg

Ionis Pharmaceuticals stock upgraded to Sell Candidate. (Updated on April 12, 2021) Sell candidate since 2021-04-06 Loss -13.50% PDF . The Ionis Pharmaceuticals stock price fell by -3.52% on the last day (Monday, 12th Apr 2021) from $42.36 to $40.87. and has now fallen 5 days in a row.During the day the stock fluctuated 3.29% from a day low at $40.76 to a day high of $42.10. Ionis is traded on the NASDAQ stock exchange under the symbol IONS.

However, the company's lackluster Q4 resul A high-level overview of Ionis Pharmaceuticals, Inc. (IONS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Fågel härma

1 day ago

View today's stock price, news and analysis for Ionis Pharmaceuticals Inc. (IONS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation The Ionis Pharmaceuticals stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. Ionis (ticker: IONS) said that Roche Holding (RHHBY), with which it is developing the drug, stopped dosing patients in the trial following an independent data-monitoring committee’s review of the The news comes as a hit to IONS stock as the drug, known as tominersen, is one of Ionis' raft of late-stage assets. Roche said it will share future plans for tominersen after the full results are Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing.

20 Apr 2018 $1 billion in cash, which will include · $625 million to purchase 11,501,153 shares of Ionis common stock at a price of · $54.34 per share, at an

Ionis Pharmaceuticals finansierar sin pipeline för mer än 40 droger. De - Fröken Investera Canopy Growth Corp Stock – How to invest in the Om du tänker på att köpa Gilead Sciences Stock, är det dags att göra det Tech Stocks Den här veckan: Apple Stock Hits New High, Snap Plummets och More 3 saker Nike Management vill du veta; Ionis Pharmaceuticals finansierar sin Ionis shares leap 30% after a drug trial goes so well, it ends early An experimental drug for an /46363493/stock-video-beetles-mate.

2021-04-06 · CARLSBAD, Calif., April 6, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it intends to offer, subject to market conditions and other factors, $500.0 million Stock quote | Ionis Pharmaceuticals, Inc. 2021-04-08 · The conversion rate will initially be 17.2902 shares of Ionis' common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $57.84 per share of Ionis Pharmaceuticals scrapped a Huntington's treatment late Monday after an independent committee questioned whether the drug's benefits outweigh its risks.In response, IONS stock plummeted. X 2020-08-14 · View the latest Ionis Pharmaceuticals Inc. (IONS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Ionis Pharmaceuticals' stock was trading at $49.14 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO).